Pfizer Agrees to $60 Million Settlement Over Nurtec Anti-Kickback Allegations

Settlement Amount:
Pfizer will pay nearly $60 million to settle claims that its subsidiary Biohaven used illegal kickbacks to drive sales of its migraine medicine Nurtec ODT1.

Allegations:
The allegations centered on Biohaven's use of illegal kickbacks to promote Nurtec ODT, a prescription migraine medication1.

Background:
This settlement comes after previous controversies, including one involving Lady Gaga, who faced backlash for promoting Nurtec ODT on her social media, with fans criticizing her for what they perceived as a "sick cash grab"2.

Legal Resolution:
The settlement marks the closure of the anti-kickback suit against Pfizer and its subsidiary Biohaven, resolving allegations of illegal marketing practices1.

Sources:

1. https://endpts.com/pfizer-inks-60m-settlement-to-close-nurtec-anti-kickback-suit/

2. https://radaronline.com/p/lady-gaga-shocked-migraine-backlash/